A Gene Editing Therapy Cut Cholesterol Levels by Half

An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.

CRISPR gene-editing works to reduce high cholesterol in a new study

An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...
Fierce Biotech

Vinay Prasad, Martin Makary unveil new FDA path for accelerating custom gene editing therapies

In a highly anticipated article, FDA officials Vinay Prasad, M.D., and Martin Makary, M.D., outlined a novel regulatory ...

Monday's Daily Dose with Monica Robins: Gene therapy breakthrough, new cholesterol drug and ...

From revolutionary CRISPR treatment to heavy drinking dangers, here's what you need to know about the latest health research.

Can a One-Time Gene Therapy Lower Cholesterol?

Researchers report early but encouraging results on an experimental gene-editing treatment for high cholesterol.
STAT

FDA chiefs offer roadmap to expand custom gene-editing treatments like Baby KJ’s

Marty Makary and Vinay Prasad offered a roadmap for expanding access to custom gene-editing treatments like the one used to ...

Harmful cholesterol levels cut in half with one-time gene editing drug in early trial

One dose of an experimental drug cover offer lifetime treatment for people with high cholesterol, but its long-term safety is ...
The Scientist

Moving Gene Editing Advances Into the Clinic

Gene therapy has long promised to provide a solution for genetic blood disorders, but delivering on that promise has proven complex due to challenges including difficulties delivering the editing ...
MIT Technology Review

Here’s the latest company planning for gene-edited babies

A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the ...